Cordis puts the nitric oxide (NO) in restenosis:
This article was originally published in Clinica
Executive Summary
Cordis and NitroMed are collaborating to develop a stent that gives off nitric oxide in an attempt to prevent restenosis. Restenosis, the re-narrowing of arteries after angioplasty, is caused by a combination of elastic recoil and uncontrolled division of cells in response to wounding. Nitric oxide can suppress the cell proliferation. Cordis and NitroMed will develop a stent coated with a nitric oxide donor for use in a variety of cardiovascular applications.